Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors

Immunotherapy is the standard of care for several cancers and the field continues to advance at a rapid pace, with novel combinations leading to indications in an increasing number of disease settings. Durable responses and long-term survival with immunotherapy have been demonstrated in some patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Kluger, Harriet, Barrett, J Carl, Gainor, Justin F, Hamid, Omid, Hurwitz, Michael, LaVallee, Theresa, Moss, Rebecca A, Zappasodi, Roberta, Sullivan, Ryan J, Tawbi, Hussein, Sharon, Elad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Position Article and Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016305/
https://www.ncbi.nlm.nih.gov/pubmed/36918224
http://dx.doi.org/10.1136/jitc-2022-005921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016305/
https://www.ncbi.nlm.nih.gov/pubmed/36918224
http://dx.doi.org/10.1136/jitc-2022-005921

Ejemplares similares